同源康医药-B(02410):中国证监会发出关于公司申请H股全流通的备案通知书

智通财经
Jan 23

智通财经APP讯,同源康医药-B(02410)发布公告,近日中国证监会已就H股全流通向公司发出备案通知书。根据备案通知书,有关公司1名股东持有460.8万股非上市股份转换为460.8万股H股的H股全流通的中国证监会备案已告完成。于完成有关转换及联交所授予上市批准后,该等460.8万股H股将于联交所主板上市及买卖。备案通知书将自中国证监会核准之日起12个月内有效。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10